Advertisement
Table 3 Biochemistry and haematology values between two treatment groups
| Lab parameter (Units) | Visit | Placebo | Active | Normal range |
|---|---|---|---|---|
| Alanine aminotransferase (IU L−1) | Baseline | 23.5 ± 6.44 | 22.8 ± 5.64 | 0 to 41 |
| Final Visit | 23.4 ± 4.81 | 28.4 ± 11.20 | ||
| Albumin (g dL−1) | Baseline | 4.2 ± 0.36 | 4.2 ± 0.70 | 3.5 to 5.2 |
| Final Visit | 4.4 ± 0.28 | 4.1 ± 0.45 | ||
| Alkaline phosphatase (U L−1) | Baseline | 76.6 ± 8.73 | 86.0 ± 5.98 | 53 to 128 |
| Final Visit | 75.9 ± 8.76 | 82.8 ± 3.44 | ||
| Aspartate aminotransferase (IU L−1) | Baseline | 24.9 ± 5.79 | 25.1 ± 5.63 | 0 to 40 |
| Final Visit | 24.9 ± 6.56 | 27.4 ± 8.47 | ||
| Blood urea nitrogen (mg dL−1) | Baseline | 12.3 ± 3.38 | 10.7 ± 1.66 | 5.0 to 24 |
| Final Visit | 11.1 ± 2.69 | 10.9 ± 1.85 | ||
| Fasting blood sugar (mg dL−1) | Baseline | 99.1 ± 2.54 | 106.2 ± 3.89 | 70 to 110 |
| Final Visit | 104.2 ± 2.99 | 120.4 ± 9.48 | ||
| LDL Cholesterol (mg dL−1) | Baseline | 105.4 ± 5.08 | 109.2 ± 5.69 | Up to 140 |
| Final Visit | 110.1 ± 4.30 | 91.3 ± 3.92 | ||
| Potassium (mEq L−1) | Baseline | 4.1 ± 0.19 | 4.1 ± 0.33 | 3.5 to 5.2 |
| Final Visit | 4.2 ± 0.18 | 4.1 ± 0.34 | ||
| Serum creatinine (mg %) | Baseline | 0.9 ± 0.12 | 0.9 ± 0.13 | 0.6 to 1.4 |
| Final Visit | 0.9 ± 0.09 | 0.9 ± 0.15 | ||
| Sodium (mEq L−1) | Baseline | 139.8 ± 1.76 | 139.3 ± 3.30 | 136 to 145 |
| Final Visit | 140.7 ± 2.58 | 139.6 ± 4.36 | ||
| Total bilirubin (mg dL−1) | Baseline | 1.2 ± 1.54 | 0.8 ± 0.27 | 0.1 to 1.2 |
| Final Visit | 0.8 ± 0.23 | 0.8 ± 0.23 | ||
| Total protein (g dL−1) | Baseline | 7.1 ± 0.56 | 7.2 ± 0.34 | 6.22 to 8.0 |
| Final Visit | 7.5 ± 0.31 | 7.3 ± 0.50 | ||
| Erythrocyte Count (*106 cells) | Baseline | 4.9 ± 0.78 | 5.0 ± 0.53 | 4.0 to 6.5 |
| Final Visit | 4.5 ± 0.70 | 4.6 ± 0.61 | ||
| Haematocrit (%) | Baseline | 40 ± 0.06 | 40 ± 0.05 | 40 to 50 |
| Final Visit | 40 ± 0.06 | 40 ± 0.06 | ||
| Haemoglobin (gm %) | Baseline | 12.8 ± 2.77 | 12.9 ± 1.87 | 11 to 16 |
| Final Visit | 13.8 ± 2.31 | 13.0 ± 2.39 | ||
| Leukocyte Count (Cells cu. mm−1) | Baseline | 6383.3 ± 16.92 | 6309.4 ± 16.32 | 4000 to 11,000 |
| Final Visit | 7328.6 ± 18.95 | 6788.2 ± 16.74 | ||
| Lymphocytes (%) | Baseline | 30 ± 0.06 | 31 ± 0.06 | 25 to 40 |
| Final Visit | 30 ± 0.06 | 30 ± 0.06 | ||
| Monocytes (%) | Baseline | 0.0 ± 0.01 | 0.0 ± 0.02 | 0 to 10 |
| Final Visit | 0.0 ± 0.01 | 0.0 ± 0.01 | ||
| Neutrophils (%) | Baseline | 60 ± 0.05 | 60 ± 0.06 | 40 to 75 |
| Final Visit | 60 ± 0.06 | 60 ± 0.07 | ||
| Basophils (%) | Baseline | 0.0 ± 0.00 | 0.0 ± 0.00 | 0 to 1 |
| Final Visit | 0.0 ± 0.00 | 0.0 ± 0.00 | ||
| Eosinpophils (%) | Baseline | 0.0 ± 0.01 | 0.0 ± 0.01 | 0 to 7 |
| Final Visit | 0.0 ± 0.01 | 0.0 ± 0.01 | ||
| Platelet Count (*105 per cu. mm) | Baseline | 2.9 ± 0.67 | 2.7 ± 0.72 | 1.5 to 4.5 |
| Final Visit | 3.2 ± 0.78 | 3.0 ± 0.66 |
